FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Germline Variants Predict Lobular Breast Cancer Recurrence

2.

A novel blood test may enable the early identification of common, fatal cancers.

3.

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

4.

Finding a clue to the origin of treatment-resistant leukemia in kids

5.

In myelofibrosis, combinations of rufolitinib reduce spleen volume.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot